Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:1288 (29 November), doi:10.1136/bmj.327.7426.1288-b
| The first 150 words of the full text of this article appear below. |
EDITORAbernethy et al identify that hypercapnia and respiratory depression are impediments to the use of opiates in patients with chronic obstructive pulmonary disease, yet they do little to allay those concerns in their report.1
Most (88%) of their patients were reported to have chronic obstructive pulmonary disease. This is a diagnosis based on spirometric assessment,2 but they present no such data. Spirometry would give confirmation of the diagnosis, prognostic information and perhaps selection criteria for the intervention. We disagree that measurement of pulmonary function would be neither generalisable nor ethical as spirometry is an easily performed, non-invasive procedure that is widely available.
The authors say that no respiratory depression was identified, but they present no data to support this. Oxygen saturation and respiratory rate, which are reported, may not identify respiratory depression. Alveolar hypoventilation, the result of respiratory depression, is a function of respiratory rate and tidal volume.
James W Berrill, house officer, medicine
James_w_berrill@hotmail.com
Seamus J Linnasne, consultant respiratory physician
Llandough Hospital, Penarth, Cardiff CF64 2XX